A DEXA Clinical Study to Evaluate the Osteointegrative Potential of Trabecular Titanium™

The purpose of this clinical trial is to evaluate the osteointegrative potential of the Trabecular TitaniumTM and to measure the pattern of changing in bone mineral density (BMD) around an uncemented acetabular cup, manufactured in Trabecular Titanium™ , during 60 months after surgery.

Inclusion Criteria:

• BMI< 40 kg/m2
• Indication suitable to the implantation of Delta TT acetabular cup (First implant)
• Idiopathic osteoarthritis
• Avascular necrosis
• Post-traumatic arthritis
• Presence of sufficient periacetabular bone stock
• Ability to understand the investigation, cooperate with the investigational procedure and willing to return to the hospital for the required post-operative follow-ups
• Written informed consent

Exclusion Criteria:

• Patients found unsuitable for an implantation of Delta TT acetabular cup (Revision)
• Patients aged 76 or older
• Haemophilic disease
• Femur neck fracture
• Insulin Dependent Diabetes Mellitus (IDDM)
• Severe kidney failure (grade 4)
• Not responder Hypo- or Hyperthyroidism
• Paget's disease
• Tumours
• Active or suspicious infections
• Neurosensory deficits or neuromuscular diseases
• Severe and impairing vascular diseases
• Known incompatibility or allergy to products materials
• Woman with pregnancy or childbearing capacity or breast-feeding
• Subjects already enrolled in other clinical trials